Top compounds associated with response to CTD-2006C1.13


Feature Type Standardized
Nominal ANOVA
mRNA barasertib CTRPv2 pan-cancer AAC 0.22 3e-10
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.28 7e-07
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA quizartinib CTRPv2 pan-cancer AAC 0.19 6e-06
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.17 7e-06
mRNA AT7867 CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA PL-DI CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA foretinib CTRPv2 pan-cancer AAC 0.16 3e-05
Download CSV